| HOME >> BIOLOGY >> TECHNOLOGY |
a record sales amount for SAFC, our Fine Chemicals unit, as we
continued to enhance our customer centric activities. Research
Essentials and Research Specialties achieved sales growth in excess of
long-term growth targets, and Research Biotech exceeded current year
growth expectations, all after factoring out a modest benefit in the
second quarter from holiday timing differences between 2008 and 2007.
And SAFC had another increase in its booked orders for future delivery
to again achieve a new record level;
-- Increasing reported and adjusted sales in CAPLA (Canada, Asia Pacific
and Latin America) markets by 19.3% and 11.3%, respectively, in Q2
2008, with a Q2 2008 revenue contribution from these markets at 20% of
sales, a one percentage point improvement over results for the
comparable quarter of 2007 and consistent with level achieved for all
of 2007. Reported quarterly sales growth in our primary focus markets
of India, Brazil and China ranged from 10% to 45% as we continued to
increase our presence in each of these markets through new sales
activities, completed and planned increases in production capacity, and
inventory stocking initiatives;
-- Increasing web-based sales through our award winning website by 21.9%.
Overall web-based sales improved to 42% of worldwide Q2 2008
Research-based sales as e-commerce sales to international (Europe and
CAPLA) customers rebounded in Q2 to increase by 32.4%. E-commerce sales
to U.S. Research customers were 52% of total U.S. Research sales, a one
percentage point improvement from
'/>"/>
| SOURCE Sigma-Aldrich Copyright©2008 PR Newswire. All rights reserved |